Colgate-Palmolive (NYSE:CL) PT Raised to $100.00 at Citigroup

Colgate-Palmolive (NYSE:CL) had its price objective raised by Citigroup from $95.00 to $100.00 in a research report released on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other equities analysts have also recently commented on the company. Stifel Nicolaus boosted their target price on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a buy rating in a research report on Wednesday, April 10th. UBS Group raised their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a buy rating in a research note on Monday, January 29th. Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an equal weight rating in a research report on Monday, January 29th. The Goldman Sachs Group started coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They issued a buy rating and a $93.00 price target on the stock. Finally, Barclays lifted their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an equal weight rating in a report on Friday, April 12th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus target price of $89.50.

Colgate-Palmolive Trading Up 1.1 %

Shares of CL opened at $87.13 on Tuesday. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $90.37. The stock has a market cap of $71.62 billion, a PE ratio of 31.34, a P/E/G ratio of 3.26 and a beta of 0.42. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. The business’s 50-day moving average price is $87.10 and its 200-day moving average price is $80.78.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the previous year, the company earned $0.77 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 6.9% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.30%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 69.06%.

Insiders Place Their Bets

In related news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares in the company, valued at approximately $1,628,484. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of the stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the sale, the executive vice president now owns 8,043 shares in the company, valued at approximately $686,470.05. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 in the last ninety days. Company insiders own 0.34% of the company’s stock.

Institutional Trading of Colgate-Palmolive

Large investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its holdings in Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after buying an additional 94,837 shares during the period. Covestor Ltd lifted its position in Colgate-Palmolive by 71.9% during the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock valued at $186,000 after buying an additional 1,025 shares during the period. Mackenzie Financial Corp increased its stake in shares of Colgate-Palmolive by 8.5% in the 1st quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after acquiring an additional 146,936 shares in the last quarter. First Western Trust Bank purchased a new stake in Colgate-Palmolive in the first quarter worth about $569,000. Finally, Wsfs Capital Management LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $288,000. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.